Provided by Tiger Trade Technology Pte. Ltd.

Heartbeam Inc

1.43
+0.140010.85%
Post-market: 1.430.00000.00%19:42 EST
Volume:571.10K
Turnover:805.77K
Market Cap:49.25M
PE:-2.18
High:1.47
Open:1.32
Low:1.30
Close:1.29
52wk High:4.00
52wk Low:0.5400
Shares:34.44M
Float Shares:24.81M
Volume Ratio:1.12
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6570
EPS(LYR):-0.7299
ROE:-792.01%
ROA:-272.38%
PB:121.32
PE(LYR):-1.96

Loading ...

Beat Holdings Expands Bitcoin ETF Position and Corrects Prior Purchase Data

TIPRANKS
·
Feb 02

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Reuters
·
Jan 22

FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup

TIPRANKS
·
Jan 12

HeartBeam Inc. to Attend JP Morgan Annual Healthcare Conference

Reuters
·
Jan 05

10% Owner Mark E. Strome Reports Disposal of HeartBeam Inc. Common Shares

Reuters
·
Dec 23, 2025

Top Midday Gainers

MT Newswires Live
·
Dec 11, 2025

Heartbeam Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 11, 2025

Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

Benzinga_recent_news
·
Dec 11, 2025

HeartBeam Wins FDA Clearance for At-Home Cable-Free 12-Lead ECG System

Reuters
·
Dec 10, 2025

Heartbeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead Ecg for at-Home Arrhythmia Assessment

THOMSON REUTERS
·
Dec 10, 2025

Heartbeam Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 08, 2025

HC Wainwright Initiates HeartBeam at Buy With $2.50 Price Target

MT Newswires Live
·
Dec 08, 2025

Top Midday Gainers

MT Newswires Live
·
Nov 29, 2025

Crude Oil Gains 1%; Tilray Brands Shares Plunge

Benzinga
·
Nov 29, 2025

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Nov 28, 2025

What's Behind HeartBeam's Over 40% After-Hours Surge?

Benzinga_recent_news
·
Nov 27, 2025

HeartBeam Pursues FDA Resolution After 12-Lead ECG Software Receives NSE Decision

Reuters
·
Nov 27, 2025

Heartbeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead Ecg Synthesis Software Application

THOMSON REUTERS
·
Nov 27, 2025

Top Midday Decliners

MT Newswires Live
·
Nov 22, 2025

Roth sees potential FDA clearance for HeartBeam despite letter

TIPRANKS
·
Nov 22, 2025